A 135 (Bupropion Hydrochloride Extended Release (SR) 200 mg)
Pill with imprint A 135 is Yellow, Elliptical/Oval and has been identified as Bupropion Hydrochloride Extended Release (SR) 200 mg. It is supplied by Actavis US.
Bupropion is used in the treatment of major depressive disorder; depression; smoking cessation; seasonal affective disorder and belongs to the drug classes miscellaneous antidepressants, smoking cessation agents. Risk cannot be ruled out during pregnancy. Bupropion 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for A 135

Bupropion Hydrochloride Extended Release (SR)
- Imprint
- A 135
- Strength
- 200 mg
- Color
- Yellow
- Size
- 17.00 mm
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- Miscellaneous antidepressants, Smoking cessation agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Actavis US
- Inactive Ingredients
-
copovidone,
silicon dioxide,
hydroxypropyl cellulose,
hypromelloses,
magnesium stearate,
microcrystalline cellulose,
polydextrose,
polyethylene glycol,
titanium dioxide,
triacetin,
ferric oxide yellow
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
67767-0135 (Discontinued) | Actavis Pharma, Inc. |
16714-0336 (Discontinued) | NorthStar Rx LLC |
Related images for "A 135"
More about bupropion
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (2,589)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: miscellaneous antidepressants
Patient resources
- Drug Information
- Bupropion Extended-Release Tablets
- Bupropion Sustained-Release Tablets (Smoking Deterrent)
- Bupropion Tablets and Sustained-Release Tablets
Other brands
Wellbutrin, Wellbutrin XL, Wellbutrin SR, Zyban, ... +5 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.